Disease | atrial fibrillation |
Comorbidity | C1561644|chronic kidney disease (ckd) |
Sentences | 6 |
PubMedID- 24709949 | The purpose of this review is to describe the burden of atrial fibrillation in patients with chronic kidney disease (ckd) and end-stage renal disease (esrd), postulate possible mechanisms to explain this burden of disease, understand the clinical consequences of atrial fibrillation and review the treatment options for atrial fibrillation specific to patients with kidney disease. |
PubMedID- 22906534 | Background: an animal model of atrial fibrillation (af) associated with chronic kidney disease (ckd) has not been available. |
PubMedID- 25332181 | Background: atrial fibrillation (af) frequently occurs in patients with chronic kidney disease (ckd); however, the long-term impact of development of af on the risk of death among patients with ckd is unknown. |
PubMedID- 21903982 | Background and objectives: the efficacy of adjusted-dose warfarin for prevention of stroke in atrial fibrillation patients with stage 3 chronic kidney disease (ckd) is unknown. |
PubMedID- 21056121 | Background: chronic kidney disease (ckd) is often associated with atrial fibrillation (af). |
PubMedID- 23275377 | Background: atrial fibrillation (af) frequently occurs in patients with chronic kidney disease (ckd). |
Page: 1